fluoxetine has been researched along with creatine in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alpert, JE; Fava, M; Moore, CM; Nierenberg, AA; Renshaw, PF; Rosenbaum, JF; Sonawalla, SB | 1 |
| De Keyser, J; Mostert, JP; Oudkerk, M; Sijens, PE | 1 |
| Atli, A; Avcu, S; Besiroglu, L; Bora, A; Bulut, MD; Ozbebit, O; Selvi, Y; Sozen, M; Unal, O | 1 |
| Fiedler, KK; Hellem, TL; Jeong, EK; Kondo, DG; Renshaw, PF; Shi, X; Sung, YH | 1 |
| Allen, PJ; D'Anci, KE; Kanarek, RB; Renshaw, PF | 1 |
| Han, F; Shi, Y; Wen, L; Xiao, B | 1 |
| Colla, AR; Cunha, MP; Lieberknecht, V; Oliveira, Á; Pazini, FL; Rodrigues, AL; Rosa, JM | 1 |
| Azevedo, D; Brocardo, PS; Colla, A; Cunha, MP; de Oliveira, J; Gil-Mohapel, J; Pazini, FL; Ramos-Hryb, AB; Rodrigues, ALS; Rosa, JM | 1 |
| Brown, J; Ettaro, R; Hoffman, MD; Kanekar, S; Lynch, C; Ombach, HJ; Renshaw, PF; Sheth, CS | 1 |
3 trial(s) available for fluoxetine and creatine
| Article | Year |
|---|---|
Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine.
Topics: Adult; Ambulatory Care; Analysis of Variance; Basal Ganglia; Biomarkers; Choline; Creatine; Cytosol; Depressive Disorder; Female; Fluoxetine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 1999 |
Fluoxetine increases cerebral white matter NAA/Cr ratio in patients with multiple sclerosis.
Topics: Administration, Oral; Adult; Antidepressive Agents, Second-Generation; Aspartic Acid; Cerebral Cortex; Creatine; Female; Fluoxetine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis | 2006 |
Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.
Topics: Adolescent; Antidepressive Agents; Creatine; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Phosphocreatine; Phosphorus; Radionuclide Imaging; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2011 |
7 other study(ies) available for fluoxetine and creatine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The involvement of distinct neural systems in patients with obsessive-compulsive disorder with autogenous and reactive obsessions.
Topics: Adult; Aspartic Acid; Choline; Creatine; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Female; Fluoxetine; Humans; Limbic System; Magnetic Resonance Spectroscopy; Male; Middle Aged; Obsessive Behavior; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2011 |
Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain; Creatine; Depression; Dietary Supplements; Disease Models, Animal; Drug Synergism; Estrus; Female; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sex Characteristics | 2012 |
Effects of fluoxetine on the amygdala and the hippocampus after administration of a single prolonged stress to male Wistar rates: In vivo proton magnetic resonance spectroscopy findings.
Topics: Amygdala; Animals; Aspartic Acid; Choline; Creatine; Fluoxetine; Hippocampus; Male; Proton Magnetic Resonance Spectroscopy; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Stress, Psychological; Treatment Outcome | 2015 |
Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corticosterone; Creatine; Depression; Disease Models, Animal; Female; Fluoxetine; Ketamine; Mice; Models, Biological; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |
Creatine Prevents Corticosterone-Induced Reduction in Hippocampal Proliferation and Differentiation: Possible Implication for Its Antidepressant Effect.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cell Differentiation; Cell Proliferation; Corticosterone; Creatine; Depression; Feeding Behavior; Female; Fluoxetine; Glial Fibrillary Acidic Protein; Hippocampus; Mice; Motor Activity; Neurons; Sucrose | 2017 |
Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression.
Topics: Animals; Brain; Creatine; Depressive Disorder, Major; Dietary Supplements; Drug Synergism; Energy Metabolism; Female; Fluoxetine; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sex Factors | 2021 |